SQM: Record Lithium Volumes Meet "Inflection Point" Claims While Iodine Quietly Anchors 42% of Gross Margin
The world's lowest-cost lithium producer survived a price trough that sank 40% of global supply. Now expanding to 260,000 tons while Tianqi exits its 22% stake and sodium-ion targets the ESS demand the recovery depends on. The iodine business nobody talks about may be the real story.
CLP, slightly higher YoY
+14% QoQ from trough
Of total gross margin
$20.3B cap / $588M NI
SQM operates the Salar de Atacama, the richest known lithium brine deposit on Earth. In 2025, while lithium prices cratered and competitors hemorrhaged cash, SQM remained profitable at prices as low as $6/kg. CEO Ricardo Ramos stated the company is "probably the only one that can have reasonable profits at today pricing." That claim appears supported by the evidence.
By Q4 2025, management was declaring a lithium price "inflection point" and reporting record quarterly sales volumes of 66,000 metric tons. The newly formed Codelco joint venture (Nova Andino Litio) resolved years of Chilean nationalization uncertainty. Production guidance for 2026 was raised to 260,000 LCE.
But beneath the recovery narrative, several tensions deserve scrutiny. Iodine, not lithium, contributed 42% of the company's gross margin in 2025. Tianqi Lithium, SQM's largest private shareholder at ~22%, is actively selling millions of shares. And the company's own supply expansion may be the very force that prevents the sustained lithium price recovery its ~35x P/E demands.
Want the full 7-lens analysis with signal assessments and model debates?
Opus + Sonnet ensemble. 7 lenses. 9 signals. 7 debates. Full evidence citations.
Signal Assessments
Salar de Atacama provides the world's lowest-cost lithium production. Profitable at $6/kg when 40% of supply was cash-negative. Iodine leadership adds a second moat.
Strong balance sheet through the downturn. Investment-grade rating maintained. CFO: 'several levers before raising capital.'
CapEx cut 22% to $2.7B while maintaining production targets. Mt. Holland expansion and Salar Futuro deferred to match market conditions.
Codelco JV resolved nationalization risk. CORFO payments align government interests. Salar Futuro environmental approval is a multi-year process.
Revenue can swing 50%+ in a year with index-linked lithium pricing. Iodine (42% of margin) prevents FRAGILE classification.
Tianqi (~22%) actively selling. No buyback possible under Chilean law. Codelco JV adds government governance. Exec comp opaque.
IFRS + Codelco JV minority interest + CORFO variable leases + prior LCE reporting confusion. Management acknowledged reporting issues.
Market frames SQM as a lithium play. Iodine is underappreciated. Own supply expansion undermines the price recovery narrative.
~35x P/E requires sustained lithium recovery, 260K LCE execution, record iodine margins, and Kwinana completion. Plausible but demanding.
Key Findings
The Cost Position That Survived the Lithium Winter
SQM's Salar de Atacama brine operation is the world's lowest-cost lithium asset. During the 2024-2025 price trough, when lithium fell from 2022 peaks of $70+/kg to under $7/kg, approximately 40% of global supply was cash-negative. SQM maintained healthy profits throughout. The cost advantage is geological (the chemistry and concentration of the brine) rather than operational, making it exceptionally durable.
The 42% Margin Anchor the Market Ignores
Iodine contributed 42% of SQM's total gross margin in 2025 with 57% adjusted margins and record pricing (~$73/kg). The x-ray contrast media market drives secular demand growth. Environmental permitting bottlenecks limit new supply, and SQM is expanding capacity to 17,000+ mt/yr through the seawater pipeline, Maria Elena, and Pampa Blanca projects. Management noted environmental restrictions are the "main bottleneck" for new entrants.
What the market sees
SQM = lithium play. Recovery narrative. EV demand growth.
What the data shows
Iodine = 42% of margin, secular growth, high barriers. A hidden anchor.
The Supply Paradox: Expanding Into Your Own Recovery
SQM is expanding lithium production from 234,000 to 260,000 LCE in 2026, targeting record volumes each quarter. This is rational: the lowest-cost producer benefits from volume growth. But every ton SQM adds is a ton that makes lithium price recovery harder. Q4 2025 sales volumes were 50%+ higher YoY. The company's "produce at full capacity" strategy is individually optimal but collectively bearish for the commodity price that its ~35x P/E embeds.
The Codelco JV: Paying 13% for Decades of Access
Nova Andino Litio (50/50 with state-owned Codelco) resolved Chile's lithium nationalization threat. The cost: 33,500 mt of lithium (~13% of Chilean output) allocated to Codelco via profit-sharing dividend. Three lenses independently concluded this was net positive, eliminating existential risk in exchange for a manageable permanent cost layer. The JV makes future political interference harder since it would harm Codelco (the government's own entity).
Where Models Disagreed
DOMINANT or DEFENSIBLE competitive position?
Opus argued DOMINANT: SQM's cost position is in a category of its own, profitable when 40% of supply was underwater. Sonnet argued DEFENSIBLE: commodity pricing limits market power regardless of cost leadership.
Adopted
DOMINANT. The cost advantage is geological and survived an extreme stress test.
Acknowledged
Commodity pricing means DOMINANT cost does not equal DOMINANT market power.
Is Tianqi's exit a lithium signal or financial housekeeping?
Opus argued Tianqi has its own debt pressures driving the sale. Sonnet argued that one of the world's most sophisticated lithium companies selling during a claimed "inflection point" is a material contrary indicator.
Unresolved
Ambiguous but material. Both motivations are plausible. The overhang is real regardless.
Key insight
Chilean law prohibits buybacks, so no mechanism exists to absorb the supply.
Does iodine diversification make revenue DURABLE or remain CONDITIONAL?
Opus argued iodine's 42% gross margin contribution, secular growth, and high barriers push classification toward DURABLE. Sonnet insisted lithium's extreme commodity sensitivity overwhelms the stabilizer.
Consensus
CONDITIONAL. Iodine prevents FRAGILE but cannot overcome index-linked lithium pricing.
Implication
Iodine is the insurance policy that keeps SQM from being a pure commodity bet.
Cross-Lens Reinforcements
3 lenses confirmed: Salar de Atacama provides a structural, geology-based cost advantage that survived the most severe lithium price downturn in a decade.
3 lenses concluded: eliminating existential nationalization risk for ~13% of Chilean output is a favorable trade that secures multi-decade access.
3 lenses flagged: 42% of gross margin from a business with secular growth, high barriers, and record pricing receives minimal market attention.
3 lenses confirmed: the ~22% holder exit creates sustained selling pressure. No buyback mechanism exists. Signal interpretation is ambiguous but impact is real.
What to Watch
Currently ~$10/kg with Q1 2026 expected "significantly stronger." Sustained below $8/kg triggers FRAGILE reclassification. Above $14/kg validates recovery. Watch quarterly realized prices.
Currently under 5% of new ESS installations. If sodium-ion captures 10%+ of ESS, it materially dents the second-largest lithium demand growth driver that management cites.
~22% ownership with ~3M shares filed for sale. Below 15% reduces overhang. Track 13G/13D amendments quarterly.
Ramp-up pushed to 2027. First lithium hydroxide shipped early 2026 but nameplate capacity remains distant. 50%+ capacity by end-2027 validates the $700M+ Australian strategy.
Record iodine prices with tight supply. More than 5,000 mt of new non-SQM capacity entering the market would pressure the 42% margin contribution that anchors earnings.
PROCEED WITH CAUTION
SQM is a structurally advantaged producer in a cyclical industry trading at a premium that demands sustained favorable conditions. The Salar de Atacama cost position is genuine and the Codelco JV resolves the nationalization overhang. Iodine provides a materially underappreciated earnings anchor. But ~35x P/E requires lithium recovery, production execution, record iodine margins, and Kwinana completion simultaneously. Tianqi's exit adds persistent technical pressure.
Path to More Favorable Assessment
- • Lithium prices sustain above $14/kg for two quarters
- • Kwinana reaches 50%+ of nameplate capacity
- • Tianqi completes its exit with minimal stock impact
- • Iodine demand growth accelerates above 3%
Path to Less Favorable Assessment
- • Lithium prices revert below $8/kg for sustained period
- • Sodium-ion captures 10%+ of ESS market
- • Salar Futuro environmental approval delayed beyond 2027
- • New iodine supply breaks the pricing environment
This analysis is for educational purposes only. It is not a recommendation to buy or sell any security.
Public Sources Used
- • SQM Annual Report (20-F) — FY2024
- • SQM Interim Reports (6-K) — 10 filings, 2025-2026
- • SQM Final Dividend Proposal (6-K) — March 2026
- • Schedule 13D/13G filings — 2015-2024
- • Q4 2025 Earnings Call Transcript (March 2, 2026)
- • Q3 2025 Earnings Call Transcript (November 19, 2025)
- • Q2 2025 Earnings Call Transcript (August 20, 2025)
- • Q1 2025 Earnings Call Transcript (May 28, 2025)
- • CourtListener litigation search results (5 historical cases)
- • Google Trends analysis (lithium price, SQM lithium, EV battery, Salar de Atacama)
Full Analysis with Signal Breakdowns
Explore the complete 7-lens assessment including debate transcripts, evidence citations, and monitoring triggers.
View SQM Analysis